Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Clinical trial data reported for meningitis vaccine

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

SmithKline Beecham Lyme disease vaccine update

Feb. 5, 1997

Tularik receives patent coverage for protein involved in immune response

Feb. 4, 1997

SKB acellular DTP vaccine approved in U.S.

Jan. 31, 1997

U.K. biotechnology company offers late-stage vaccine for licensing

Jan. 31, 1997

Astra investigates H. pylori vaccines

Jan. 31, 1997

Repligen and Pfizer initiate drug discovery collaboration

Jan. 30, 1997

FDA to review generic immunosuppressant

Jan. 27, 1997

Peptide Therapeutics and Medeva collaborate on vaccine development

Jan. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...